TBCRC 011: Targeting the androgen receptor (AR) for the treatment of AR+/ER-/PR-metastatic breast cancer (MBC) Meeting Abstract


Authors: Gucalp, A.; Tolaney, S. M.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; Blackwell, K. L.; Rugo, H. S.; Nabell, L.; Abbruzzi, A.; Gonzalez, J.; Giri, D. D.; Patil, S.; Feigin, K.; D'Andrea, G.; Theodoulou, M.; Drullinsky, P.; Sklarin, N. T.; Hudis, C.; Traina, T. A.; Translational Breast Cancer Research Consortium
Abstract Title: TBCRC 011: Targeting the androgen receptor (AR) for the treatment of AR+/ER-/PR-metastatic breast cancer (MBC)
Meeting Title: 47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 15 Suppl.
Meeting Dates: 2011 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-05-20
Language: English
ACCESSION: WOS:000208880304547
DOI: 10.1200/jco.2011.29.15_suppl.tps122
PROVIDER: wos
Notes: Meeting Abstract: TPS122 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Kimberly Nicole Feigin
    33 Feigin
  2. Sujata Patil
    511 Patil
  3. Clifford Hudis
    905 Hudis
  4. Nancy T Sklarin
    54 Sklarin
  5. Dilip D Giri
    184 Giri
  6. Ayca Gucalp
    113 Gucalp
  7. Tiffany A Traina
    250 Traina
  8. Alyson Merced
    13 Merced